Showing 15,441 - 15,460 results of 104,467 for search '(( 50 ((ns decrease) OR (we decrease)) ) OR ( 5 ((wt decrease) OR (a decrease)) ))', query time: 1.68s Refine Results
  1. 15441
  2. 15442

    Transmission electron micrographs of step 5 spermatids. by Yonggang Lu (358237)

    Published 2017
    “…<p><b>(A)</b> As the nuclear size (N) of step 5 spermatids decreases, the decondensed chromosomes are aggregated into a retiform pattern. …”
  3. 15443
  4. 15444
  5. 15445
  6. 15446

    vFLIP is not visible in cells expressing RTA. by Elana S. Ehrlich (532800)

    Published 2014
    “…<p>vFLIP expression is decreased in 293T cells cotransfected with RTA. 293T cells were transfected with myc tagged vFLIP and RTA where indicated. vFLIP was detected with anti-myc antibody (Millipore) followed by a rhodamine conjugated secondary antibody (Jackson ImmunoResearch). …”
  7. 15447

    A Family of Vanadate Esters of Monoionized and Diionized Aromatic 1,2-Diols: Synthesis, Structure, and Redox Activity by Bharat Baruah (1345038)

    Published 2002
    “…In solution each ester gives rise to a single <sup>51</sup>V NMR signal (no diastereoisomers), which generally shifts downfield with a decrease in the ester LMCT band energy. …”
  8. 15448

    Heteroplasmy evolution of cybrid clone V_50. by Anton K. Raap (109844)

    Published 2012
    “…<p>(A) Average cellular mutation load decreases with increasing passage number of clone V_50. …”
  9. 15449
  10. 15450
  11. 15451

    Table 1_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”
  12. 15452

    Table 3_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”
  13. 15453

    Table 2_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”
  14. 15454

    Conservation of superfamilies within five Asgard proteomes. by Steven Russum (10475294)

    Published 2021
    “…This figure was generated using Anvi’o [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0247806#pone.0247806.ref160" target="_blank">160</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0247806#pone.0247806.ref161" target="_blank">161</a>].…”
  15. 15455

    Social robot PIO (version 3.5). by Jun-Seo Lim (21161776)

    Published 2025
    “…The difference between the two groups was statistically significant (<i>t</i> = 3.94, <i>p</i><.001). Depression decreased -0.7±3.48 in the experimental group, from 5.9±4.74 before intervention to 5.2±4.65 after intervention, and decreased by -0.2±3.42, from 6.5±4.69 before intervention to 6.4±4.08 after intervention, in the control group, but the difference between the two groups was not statistically significant (<i>z</i> = -0.59, <i>p</i> =.557). …”
  16. 15456

    Effect of SBS on rumen fermentation (n = 5). by Minghui Zhang (298745)

    Published 2025
    “…The pre-experimental period was 10 days, followed by a 70 days formal experimental period. The results showed that: (1) Compared with the CON group, the dressing percentage and eye muscle area in the SBS24 group significantly increased (<i>P</i> < 0.05); (2) Compared with the CON group, the butyrate content and total fatty acid content inthe SBS24 group significantly increased (<i>P</i> < 0.05); (3) Compared with the CON group, the Simpson index of the SBS groups significantly increased (<i>P</i> < 0.05), while the Shannon index of the SBS12, SBS18, and SBS24 groups significantly decreased (<i>P</i> < 0.01). …”
  17. 15457
  18. 15458

    TMD-5 intrinsic Trp fluorescence assay. by Xiaohui Wang (19899)

    Published 2012
    “…(b), Pentamidine decreases Trp emission fluorescence intensity of TMD-5 in 150 µM C14 betaine and 50 mM HEPES (pH = 7.4) buffer in a dose-dependent manner. …”
  19. 15459

    Inhibition correlates with cellular PmV levels. by Luca Gambini (826027)

    Published 2015
    “…DC6 clone expresses PmV-GFP chimera under regulation of the native promoter [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142509#pone.0142509.ref015" target="_blank">15</a>]; G6 clone, the PmV-GFP-DD chimera under regulation of the native promoter (this paper) and #3 clone (episomally expressing PmV-GFP chimera under <i>Hsp86-5'</i>, a strong and constitutive promoter) [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142509#pone.0142509.ref015" target="_blank">15</a>]. …”
  20. 15460

    V2G controls parameters [36]. by Mahmoud M. Hussein (16965014)

    Published 2023
    “…Both of these components are designed for autonomous vehicle-to-grid (V2G) devices. The proposed control technique is applied to a three-area power system, where the V2G scheme is located in Area-1. …”